COVID-19 trials registries data warehouse

 Return to trial list

Trial - NCT04349618


Column Value
Trial registration number NCT04349618
Full text link
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

First author
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

Jean-Christophe RICHARD, Pr

Contact
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

j-christophe.richard@chu-lyon.fr

Registration date
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

2020-04-16

Recruitment status
Last imported at : April 21, 2023, 8 p.m.
Source : ClinicalTrials.gov

Unknown

Study design
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

RCT

Allocation
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

Randomized

Design
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

Parallel

Masking
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

Open label

Center
Last imported at : March 15, 2023, 4 a.m.
Source : ClinicalTrials.gov

multi-center

Study aim
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

Treatment

Inclusion criteria
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

inclusion criteria: - adults aged 18 years or older - ards according to the berlin definition - covid-19 pneumonia confirmed by rt-pcr - acute respiratory failure not fully explained by left ventricular failure or sodium overload - bilateral pulmonary radiological opacities not fully explained by pleural effusions or atelectasis or nodules - invasive mechanical ventilation with pao2/fio2 ≤ 150 mm hg and peep ≥ 5 cm h2o with a tidal volume below or equal to 6 ml per kilogram of predicted body weight - continuous intravenous sedation as part of ards treatment

Exclusion criteria
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

- exclusion criteria related to ards history - ards onset more than 48 hours before inclusion - previous inclusion in present study - exclusion criteria related to ards severity or complications - arterial ph < 7.21 despite respiratory rate set to 35/min at the time of inclusion - patient under any extracorporeal co2 removal technique or ecmo - pneumothorax or bronchopleural fistula - exclusion criteria related to comorbidities - suspected intracranial hypertension - severe chronic obstructive pulmonary disease defined by a gold score ≥ 3 - chronic respiratory failure under home oxygen or non-invasive ventilation - chronic respiratory failure requiring long term oxygen or non-invasive ventilation - obesity with body weight over height ratio greater than 1 kg/cm - sickle cell disease - bone marrow transplant < 6 months - burn injury with extension greater than 30% of body surface area - cirrhosis with child-pugh score c - advance directives to withhold or withdraw life sustaining treatment - exclusion criteria related to legislation - patient under an exclusion period relative to participation to another clinical trial, or inclusion into a clinical trial interfering with the ventilatory strategies - pregnancy, lactating women - patient under a legal protective measure. - lack of affiliation to social security as required by french regulation - lack of written informed consent by patient or next of kin (unless if recourse to the emergency procedure in the absence of a loved one)

Number of arms
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

2

Funding
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

Hospices Civils de Lyon

Inclusion age min
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

18

Inclusion age max
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

None

Countries
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

France

Type of patients
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

Moderate/severe disease at enrollment

Severity scale
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

4: Moderate/severe disease at enrollment

Total sample size
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

200

primary outcome
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

A composite score based on all-cause mortality and the number of ventilator free-days (VFD)

Notes
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

None

Phase
Last imported at : Nov. 16, 2021, 6:30 p.m.
Source : ClinicalTrials.gov

Not reported

Arms
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

[{"arm_notes": "", "treatment_id": 1032, "treatment_name": "Protective ventilation", "treatment_type": "Respiratory support", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "", "treatment_id": 1330, "treatment_name": "Ultra protective ventilation", "treatment_type": "Respiratory support", "pharmacological_treatment": "Non pharmacological treatment"}]